• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cadre Holdings Reports Third Quarter 2025 Financial Results

    11/4/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care
    Get the next $CDRE alert in real time by email

    Grew Quarterly Net Sales 42% and Gross Profit 66% Year-Over-Year

    Increased Quarterly Adjusted EBITDA of $29.8 Million and Expanded Adjusted EBITDA Margin of 19.1%

    Organic Backlog Increased $20 Million from Q2 to Q3

    Med-Eng Awarded $50 Million IDIQ with DoD – First PO issued for $10 Million to be Shipped in 2026

    Agrees to Acquire TYR Tactical, Leading Provider of Plate Carriers, Vests, Hard Armor, and Shields

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three and nine months ended September 30, 2025.

    • Net sales of $155.9 million for the third quarter; net sales of $443.1 million for the nine months ended September 30, 2025.
    • Gross profit margin of 42.7% for the third quarter; gross profit margin of 42.2% for the nine months ended September 30, 2025.
    • Net income of $10.9 million, or $0.27 per diluted share, for the third quarter; net income of $32.4 million, or $0.79 per diluted share, for the nine months ended September 30, 2025.
    • Adjusted EBITDA of $29.8 million for the third quarter; Adjusted EBITDA of $77.3 million for the nine months ended September 30, 2025.
    • Adjusted EBITDA margin of 19.1% for the third quarter; Adjusted EBITDA margin of 17.4% for the nine months ended September 30, 2025.
    • Declared quarterly cash dividend of $0.095 per share in October 2025.

    "We are pleased to report another quarter of strong performance, driven by Cadre's industry leading brands and favorable trends across our law enforcement, first responder, military, and nuclear end-markets," said Warren Kanders, CEO and Chairman. "Our teams delivered results above expectations, while expanding our backlog significantly and advancing Cadre's track record of consistent and stable growth despite a dynamic operating environment. Revenue, gross profit, net income, and Adjusted EBITDA increased significantly this quarter, with an Adjusted EBITDA margin that improved 670 basis points year-over-year."

    Mr. Kanders added, "Our recently announced agreement to acquire TYR Tactical marks Cadre's sixth and largest acquisition since going public and a meaningful step forward in strengthening our diversified platform of durable safety businesses. Cadre's disciplined M&A program is crucial to accelerating long-term growth, and we are excited to have once again delivered on our pledge to capitalize on attractive inorganic opportunities. Building on our current momentum, we remain focused on pursuing additional transactions in line with our highly selective key criteria and continuing to take advantage of the free cash flow generated by the strong and recurring demand for our mission-critical safety and survivability equipment."

    Third Quarter and Nine-Month 2025 Operating Results

    For the quarter ended September 30, 2025, Cadre generated net sales of $155.9 million, as compared to $109.4 million for the quarter ended September 30, 2024. This increase was primarily a result of recent acquisitions and strong demand for armor and duty gear products, as well as the impact of the 2024 cyber incident on the comparable period.

    For the nine months ended September 30, 2025, Cadre generated net sales of $443.1 million, as compared to $391.6 million for the nine months ended September 30, 2024, also mainly driven by recent acquisitions, as well as strong demand for nuclear safety and crowd control products.

    For the quarter ended September 30, 2025, Cadre generated gross profit of $66.6 million, as compared to $40.0 million for the quarter ended September 30, 2024. For the nine months ended September 30, 2025, Cadre generated gross profit of $187.0 million, as compared to $156.3 million for the prior year period.

    Gross profit margin was 42.7% for the quarter ended September 30, 2025, as compared to 36.6% for the quarter ended September 30, 2024, mainly driven by increased volume, favorable pricing net of material inflation, and a decrease in inventory step-up amortization. Gross profit margin was 42.2% for the nine months ended September 30, 2025, as compared to 39.9% for the prior year period.

    Net income was $10.9 million for the quarter ended September 30, 2025, as compared to net income of $3.7 million for the quarter ended September 30, 2024. The increase was primarily as a result of increased gross profit, partially offset by increases in selling, general and administrative expenses, as well as other costs.

    Net income was $32.4 million for the nine months ended September 30, 2025, as compared to net income of $23.2 million for the prior year period, primarily as a result of increased gross profit and gains from foreign exchange rates partially offset by increases in compensation expense, interest expense and provision for taxes.

    Cadre generated $29.8 million of Adjusted EBITDA for the quarter ended September 30, 2025, as compared to $13.5 million for the quarter ended September 30, 2024. Adjusted EBITDA margin was 19.1% for the quarter ended September 30, 2025, as compared to 12.4% for the prior year period.

    Cadre generated $77.3 million of Adjusted EBITDA for the nine months ended September 30, 2025, as compared to $66.3 million for the prior period. Adjusted EBITDA margin was 17.4% for the nine months ended September 30, 2025, as compared to 16.9% for the prior year period.

    Product segment gross margin was 43.9% and 43.3% for the third quarter and first nine months of 2025, respectively, compared to 37.4% and 40.7% for the prior year periods.

    Distribution segment gross margin was 21.3% and 22.0% for the third quarter and first nine months of 2025, respectively, compared to 21.9% and 22.9% for the prior year periods.

    Liquidity, Cash Flows and Capital Allocation

    • Cash and cash equivalents increased by $25.9 million from $124.9 million as of December 31, 2024 to $150.9 million as of September 30, 2025.
    • Total debt increased by $88.0 million from $223.2 million as of December 31, 2024 to $311.2 million as of September 30, 2025.
    • Net debt (total debt net of cash and cash equivalents) increased by $62.1 million from $98.3 million as of December 31, 2024 to $160.4 million as of September 30, 2025.
    • Capital expenditures totaled $0.6 million for the third quarter and $3.6 million for the nine months ended September 30, 2025, compared with $1.1 million for the third quarter and $4.5 million for the nine months ended September 30, 2024.

    Acquisition of TYR Tactical

    On October 28, 2025, Cadre announced it has entered into a definitive agreement to acquire TYR Tactical, LLC, a leading global manufacturer of tactical gear and equipment for military, law enforcement, and government agencies worldwide. TYR Tactical produced approximately $92.6 million of revenue in the year ended December 31, 2024, and is expected to be immediately accretive to earnings and Adjusted EBITDA margins. The total consideration is $175 million and is anticipated to close in the first half of 2026.

    Med-Eng Wins $50 Million Contract with the Department of Defense

    On September 26, 2025, Cadre subsidiary Med-Eng, LLC was awarded a $50 million Indefinite Delivery / Indefinite Quantity (ID/IQ) contract by the United States Department of Defense (DoD), known as the Blast Exposure Monitoring System (BEMO). At the time of award, Med-Eng received the first purchase order for $10 million to be shipped in 2026.

    Dividend

    On October 21, 2025, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on November 14, 2025 to shareholders of record as of the close of business on the record date of October 31, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors.

    2025 Outlook

    For the full year 2025, Cadre expects to generate net sales in the range of $624 million to $630 million and Adjusted EBITDA in the range of $112 million and $116 million. We expect capital expenditures to be in the range of $7 million to $8 million. Cadre has not provided net income guidance due to the inherent difficulty of forecasting certain types of expenses and gains, which affect net income but not Adjusted EBITDA. Therefore, we do not provide a reconciliation of Adjusted EBITDA guidance to net income guidance.

    Conference Call

    Management will host a conference call on Wednesday, November 5, 2025, at 10:00 a.m. EST to discuss the latest corporate developments and financial results. The dial-in number for callers in the US is (800)-715-9871 and the dial-in number for international callers is 646-307-1963. The access code for all callers is 9511718. A live webcast will also be available on the Company's website at https://www.cadre-holdings.com/.

    A replay of the call will be available through November 19, 2025. To access the replay, please dial 800-770-2030 in the U.S. or +1-609-800-9909 if outside the U.S., and then enter the access code 9511718.

    About Cadre

    Headquartered in Jacksonville, Florida, Cadre is a global leader in the manufacturing and distribution of safety products. Cadre's equipment provides critical protection to allow users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. The Company's core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Our highly engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Our key brands include Safariland® and Med-Eng®, amongst others.

    Use of Non-GAAP Measures

    The Company reports its financial results in accordance with U.S. generally accepted accounting principles ("GAAP"). The press release contains the non-GAAP measures: (i) earnings before interest, taxes, other income or expense, depreciation and amortization ("EBITDA"), (ii) Adjusted EBITDA, (iii) Adjusted EBITDA margin and (iv) last twelve months Adjusted EBITDA. The Company believes the presentation of these non-GAAP measures provides useful information for the understanding of its ongoing operations and enables investors to focus on period- over-period operating performance, and thereby enhances the user's overall understanding of the Company's current financial performance relative to past performance and provides, along with the nearest GAAP measures, a baseline for modeling future earnings expectations. Non-GAAP measures are reconciled to comparable GAAP financial measures within this press release. We do not provide a reconciliation of the non-GAAP guidance measure Adjusted EBITDA for the fiscal year 2025 to net income for the fiscal year 2025, the most comparable GAAP financial measure, due to the inherent difficulty of forecasting certain types of expenses and gains, without unreasonable effort, which affect net income but not Adjusted EBITDA. The Company cautions that non-GAAP measures should be considered in addition to, but not as a substitute for, the Company's reported GAAP results. Additionally, the Company notes that there can be no assurance that the above referenced non-GAAP financial measures are comparable to similarly titled financial measures used by other publicly traded companies.

    Forward-Looking Statements

    Please note that in this press release we may use words such as "appears," "anticipates," "believes," "plans," "expects," "intends," "future," and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements. Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this press release, include, but are not limited to, those risks and uncertainties more fully described from time to time in the Company's public reports filed with the Securities and Exchange Commission, including under the section titled "Risk Factors" in the Company's Annual Report on Form 10-K, and/or Quarterly Reports on Form 10-Q, as well as in the Company's Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release and speak only as of the date hereof. We assume no obligation to update any forward- looking statements to reflect events or circumstances after the date of this press release.

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (Unaudited)

    (In thousands, except share and per share amounts)

     

     

     

     

     

     

     

     

     

    September 30, 2025

     

    December 31, 2024

    Assets

     

     

     

     

     

     

    Current assets

     

     

     

     

     

     

    Cash and cash equivalents

     

    $

    150,875

     

    $

    124,933

     

    Accounts receivable, net of allowance for doubtful accounts of $826 and $876, respectively

     

     

    99,426

     

     

    93,523

     

    Inventories

     

     

    112,201

     

     

    82,351

     

    Prepaid expenses

     

     

    12,474

     

     

    19,027

     

    Other current assets

     

     

    11,240

     

     

    7,737

     

    Total current assets

     

     

    386,216

     

     

    327,571

     

    Property and equipment, net of accumulated depreciation and amortization of $60,893 and $54,384, respectively

     

     

    77,590

     

     

    45,243

     

    Operating lease assets

     

     

    21,719

     

     

    15,454

     

    Deferred tax assets, net

     

     

    4,857

     

     

    4,552

     

    Intangible assets, net

     

     

    117,909

     

     

    107,544

     

    Goodwill

     

     

    179,169

     

     

    148,157

     

    Other assets

     

     

    4,595

     

     

    4,192

     

    Total assets

     

    $

    792,055

     

    $

    652,713

     

     

     

     

     

     

     

     

    Liabilities, Mezzanine Equity and Shareholders' Equity

     

     

     

     

     

     

    Current liabilities

     

     

     

     

     

     

    Accounts payable

     

    $

    26,997

     

    $

    29,644

     

    Accrued liabilities

     

     

    61,363

     

     

    46,413

     

    Income tax payable

     

     

    1,418

     

     

    6,693

     

    Current portion of long-term debt

     

     

    16,266

     

     

    11,375

     

    Total current liabilities

     

     

    106,044

     

     

    94,125

     

    Long-term debt

     

     

    294,971

     

     

    211,830

     

    Long-term operating lease liabilities

     

     

    16,033

     

     

    10,733

     

    Deferred tax liabilities

     

     

    24,110

     

     

    18,758

     

    Other liabilities

     

     

    10,523

     

     

    5,752

     

    Total liabilities

     

     

    451,681

     

     

    341,198

     

     

     

     

     

     

     

     

    Mezzanine equity

     

     

     

     

     

     

    Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2025 and December 31, 2024)

     

     

    —

     

     

    —

     

     

     

     

     

     

     

     

    Shareholders' equity

     

     

     

     

     

     

    Common stock ($0.0001 par value, 190,000,000 shares authorized, 40,681,668 and 40,607,988 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively)

     

     

    4

     

     

    4

     

    Additional paid-in capital

     

     

    312,910

     

     

    306,821

     

    Accumulated other comprehensive income (loss)

     

     

    565

     

     

    (1,389

    )

    Accumulated earnings

     

     

    26,895

     

     

    6,079

     

    Total shareholders' equity

     

     

    340,374

     

     

    311,515

     

    Total liabilities, mezzanine equity and shareholders' equity

     

    $

    792,055

     

    $

    652,713

     

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (Unaudited)

    (In thousands, except share and per share amounts)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended September 30,

     

    Nine Months Ended September 30,

     

     

    2025

     

    2024

     

    2025

     

    2024

    Net sales

     

    $

    155,869

     

     

    $

    109,408

     

     

    $

    443,084

     

     

    $

    391,577

     

    Cost of goods sold

     

     

    89,244

     

     

     

    69,392

     

     

     

    256,079

     

     

     

    235,283

     

    Gross profit

     

     

    66,625

     

     

     

    40,016

     

     

     

    187,005

     

     

     

    156,294

     

    Operating expenses

     

     

     

     

     

     

     

     

     

     

     

     

    Selling, general and administrative

     

     

    45,627

     

     

     

    33,981

     

     

     

    132,509

     

     

     

    113,277

     

    Restructuring and transaction costs

     

     

    2,216

     

     

     

    515

     

     

     

    6,240

     

     

     

    3,621

     

    Related party expense

     

     

    108

     

     

     

    94

     

     

     

    1,345

     

     

     

    2,038

     

    Total operating expenses

     

     

    47,951

     

     

     

    34,590

     

     

     

    140,094

     

     

     

    118,936

     

    Operating income

     

     

    18,674

     

     

     

    5,426

     

     

     

    46,911

     

     

     

    37,358

     

    Other expense

     

     

     

     

     

     

     

     

     

     

     

     

    Interest expense, net

     

     

    (3,028

    )

     

     

    (1,991

    )

     

     

    (8,849

    )

     

     

    (5,631

    )

    Other (expense) income, net

     

     

    (802

    )

     

     

    1,555

     

     

     

    6,599

     

     

     

    (225

    )

    Total other expense, net

     

     

    (3,830

    )

     

     

    (436

    )

     

     

    (2,250

    )

     

     

    (5,856

    )

    Income before provision for income taxes

     

     

    14,844

     

     

     

    4,990

     

     

     

    44,661

     

     

     

    31,502

     

    Provision for income taxes

     

     

    (3,903

    )

     

     

    (1,335

    )

     

     

    (12,261

    )

     

     

    (8,352

    )

    Net income

     

    $

    10,941

     

     

    $

    3,655

     

     

    $

    32,400

     

     

    $

    23,150

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income per share:

     

     

     

     

     

     

     

     

     

     

     

     

    Basic

     

    $

    0.27

     

     

    $

    0.09

     

     

    $

    0.80

     

     

    $

    0.58

     

    Diluted

     

    $

    0.27

     

     

    $

    0.09

     

     

    $

    0.79

     

     

    $

    0.58

     

    Weighted average shares outstanding:

     

     

     

     

     

     

     

     

     

     

     

     

    Basic

     

     

    40,666,861

     

     

     

    40,607,988

     

     

     

    40,649,339

     

     

     

    39,723,702

     

    Diluted

     

     

    40,977,677

     

     

     

    40,949,461

     

     

     

    40,964,737

     

     

     

    40,118,729

     

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

    Nine Months Ended September 30,

     

     

    2025

     

    2024

    Cash Flows From Operating Activities:

     

     

     

     

     

     

    Net income

     

    $

    32,400

     

     

    $

    23,150

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

     

     

     

    Depreciation and amortization

     

     

    13,908

     

     

     

    12,325

     

    Amortization of original issue discount and debt issue costs

     

     

    1,075

     

     

     

    787

     

    Amortization of inventory step-up

     

     

    826

     

     

     

    3,851

     

    Deferred income taxes

     

     

    (4,163

    )

     

     

    (11,627

    )

    Stock-based compensation

     

     

    6,840

     

     

     

    6,255

     

    Remeasurement of contingent consideration

     

     

    1,489

     

     

     

    685

     

    (Recoveries from) provision for losses on accounts receivable

     

     

    (190

    )

     

     

    757

     

    Unrealized foreign exchange transaction gain

     

     

    (2,275

    )

     

     

    (788

    )

    Other loss

     

     

    268

     

     

     

    355

     

    Changes in operating assets and liabilities, net of impact of acquisitions:

     

     

     

     

     

     

    Accounts receivable

     

     

    19,360

     

     

     

    162

     

    Inventories

     

     

    (14,748

    )

     

     

    (2,589

    )

    Prepaid expenses and other assets

     

     

    4,607

     

     

     

    (4,161

    )

    Accounts payable and other liabilities

     

     

    (16,942

    )

     

     

    (21,096

    )

    Net cash provided by operating activities

     

     

    42,455

     

     

     

    8,066

     

    Cash Flows From Investing Activities:

     

     

     

     

     

     

    Purchase of property and equipment

     

     

    (3,582

    )

     

     

    (4,381

    )

    Proceeds from disposition of property and equipment

     

     

    6

     

     

     

    74

     

    Business acquisitions, net of cash acquired

     

     

    (89,590

    )

     

     

    (141,813

    )

    Net cash used in investing activities

     

     

    (93,166

    )

     

     

    (146,120

    )

    Cash Flows From Financing Activities:

     

     

     

     

     

     

    Proceeds from revolving credit facilities

     

     

    —

     

     

     

    5,500

     

    Principal payments on revolving credit facilities

     

     

    —

     

     

     

    (5,500

    )

    Proceeds from term loans

     

     

    97,500

     

     

     

    80,000

     

    Principal payments on term loans

     

     

    (9,723

    )

     

     

    (9,562

    )

    Principal payments on insurance premium financing

     

     

    —

     

     

     

    (2,187

    )

    Payments for debt issuance costs

     

     

    —

     

     

     

    (844

    )

    Taxes paid in connection with employee stock transactions

     

     

    (1,185

    )

     

     

    (5,311

    )

    Proceeds from secondary offering, net of underwriter discounts

     

     

    —

     

     

     

    91,776

     

    Deferred offering costs

     

     

    —

     

     

     

    (683

    )

    Dividends distributed

     

     

    (11,584

    )

     

     

    (10,395

    )

    Other

     

     

    344

     

     

     

    37

     

    Net cash provided by financing activities

     

     

    75,352

     

     

     

    142,831

     

    Effect of foreign exchange rates on cash and cash equivalents

     

     

    1,301

     

     

     

    521

     

    Change in cash and cash equivalents

     

     

    25,942

     

     

     

    5,298

     

    Cash and cash equivalents, beginning of period

     

     

    124,933

     

     

     

    87,691

     

    Cash and cash equivalents, end of period

     

    $

    150,875

     

     

    $

    92,989

     

    Supplemental Disclosure of Cash Flows Information:

     

     

     

     

     

     

    Cash paid for income taxes, net

     

    $

    22,545

     

     

    $

    22,761

     

    Cash paid for interest

     

    $

    13,075

     

     

    $

    10,523

     

    Supplemental Disclosure of Non-Cash Investing and Financing Activities:

     

     

     

     

     

     

    Accruals and accounts payable for capital expenditures

     

    $

    16

     

     

    $

    112

     

    CADRE HOLDINGS, INC.

    SEGMENT INFORMATION

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended September 30, 2025

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    138,789

     

    $

    26,483

     

    $

    (9,403

    )

     

    $

    155,869

    Cost of goods sold

     

     

    77,862

     

     

    20,843

     

     

    (9,461

    )

     

     

    89,244

    Gross profit

     

    $

    60,927

     

    $

    5,640

     

    $

    58

     

     

    $

    66,625

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended September 30, 2024

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    96,493

     

    $

    17,836

     

    $

    (4,921

    )

     

    $

    109,408

    Cost of goods sold

     

     

    60,386

     

     

    13,936

     

     

    (4,930

    )

     

     

    69,392

    Gross profit

     

    $

    36,107

     

    $

    3,900

     

    $

    9

     

     

    $

    40,016

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Nine Months Ended September 30, 2025

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    391,659

     

    $

    79,853

     

    $

    (28,428

    )

     

    $

    443,084

    Cost of goods sold

     

     

    222,189

     

     

    62,293

     

     

    (28,403

    )

     

     

    256,079

    Gross profit

     

    $

    169,470

     

    $

    17,560

     

    $

    (25

    )

     

    $

    187,005

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Nine Months Ended September 30, 2024

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    343,711

     

    $

    71,615

     

    $

    (23,749

    )

     

    $

    391,577

    Cost of goods sold

     

     

    203,771

     

    $

    55,216

     

    $

    (23,704

    )

     

     

    235,283

    Gross profit

     

    $

    139,940

     

    $

    16,399

     

    $

    (45

    )

     

    $

    156,294

    _______________________

    (1)

    Reconciling items consist primarily of intercompany eliminations and items not directly attributable to operating segments.

    CADRE HOLDINGS, INC.

    RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Year ended

     

    Three Months Ended

     

    Nine Months Ended

     

    Last Twelve

     

     

    December 31,

     

    September 30,

     

    September 30,

     

    Months

     

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

     

    September 30, 2025

    Net income

     

    $

    36,133

     

    $

    10,941

     

    $

    3,655

     

     

    $

    32,400

     

     

    $

    23,150

     

    $

    45,383

     

    Add back:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

     

    16,420

     

     

    5,376

     

     

    3,763

     

     

     

    13,908

     

     

     

    12,325

     

     

    18,003

     

    Interest expense, net

     

     

    7,822

     

     

    3,028

     

     

    1,991

     

     

     

    8,849

     

     

     

    5,631

     

     

    11,040

     

    Provision for income taxes

     

     

    18,085

     

     

    3,903

     

     

    1,335

     

     

     

    12,261

     

     

     

    8,352

     

     

    21,994

     

    EBITDA

     

    $

    78,460

     

    $

    23,248

     

    $

    10,744

     

     

    $

    67,418

     

     

    $

    49,458

     

    $

    96,420

     

    Add back:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Restructuring and transaction costs(1)

     

     

    7,757

     

     

    2,216

     

     

    515

     

     

     

    7,240

     

     

     

    5,371

     

     

    9,626

     

    Other expense (income), net(2)

     

     

    4,721

     

     

    802

     

     

    (1,555

    )

     

     

    (6,599

    )

     

     

    225

     

     

    (2,103

    )

    Stock-based compensation expense(3)

     

     

    8,369

     

     

    2,447

     

     

    2,104

     

     

     

    6,840

     

     

     

    6,255

     

     

    8,954

     

    Stock-based compensation payroll tax expense(4)

     

     

    441

     

     

    —

     

     

    —

     

     

     

    92

     

     

     

    441

     

     

    92

     

    LTIP bonus(5)

     

     

    49

     

     

    —

     

     

    —

     

     

     

    —

     

     

     

    49

     

     

    —

     

    Amortization of inventory step-up(6)

     

     

    3,858

     

     

    470

     

     

    1,541

     

     

     

    826

     

     

     

    3,851

     

     

    833

     

    Contingent consideration expense(7)

     

     

    1,185

     

     

    632

     

     

    176

     

     

     

    1,489

     

     

     

    685

     

     

    1,989

     

    Adjusted EBITDA

     

    $

    104,840

     

    $

    29,815

     

    $

    13,525

     

     

    $

    77,306

     

     

    $

    66,335

     

    $

    115,811

     

    Adjusted EBITDA margin(8)

     

     

    18.5

    %

     

    19.1

    %

     

    12.4

     

    %

     

    17.4

     

    %

     

    16.9

    %

     

     

    _______________________

    (1)

    Reflects the "Restructuring and transaction costs" line item on our condensed consolidated statements of operations, which primarily includes transaction costs composed of legal and consulting fees. In addition, this line item reflects a $1.0 million fee paid to Kanders & Company, Inc. for services related to the acquisition of Zircaloy for the nine months ended September 30, 2025 and a $1.8 million fee paid to Kanders & Company, Inc. for services related to the acquisition of Alpha Safety for the nine months ended September 30, 2024, which are included in related party expense in the Company's condensed consolidated statements of operations.

    (2)

    Reflects the "Other (expense) income, net" line item on our condensed consolidated statements of operations and primarily includes transaction gains and losses due to fluctuations in foreign currency exchange rates.

    (3)

    Reflects compensation expense related to equity and liability classified stock-based compensation plans.

    (4)

    Reflects payroll taxes associated with vested stock-based compensation awards.

    (5)

    Reflects the cost of a cash-based long-term incentive plan awarded to employees that vests over three years.

    (6)

    Reflects amortization expense related to the step-up inventory adjustment recorded as a result of our recent acquisitions.

    (7)

    Reflects contingent consideration expense related to the acquisition of ICOR.

    (8)

    Reflects Adjusted EBITDA / Net sales for the relevant periods.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251104622714/en/

    Gray Hudkins

    Cadre Holdings, Inc.

    203-550-7148

    [email protected]



    Investor Relations:

    The IGB Group

    Leon Berman / Matt Berkowitz

    212-477-8438 / 212-227-7098

    Get the next $CDRE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CDRE

    DatePrice TargetRatingAnalyst
    8/13/2025$26.00Neutral → Underperform
    BofA Securities
    6/13/2025$38.00Buy → Neutral
    BofA Securities
    2/21/2024$32.00 → $38.00Buy
    ROTH MKM
    1/22/2024Outperform → Mkt Perform
    Raymond James
    9/6/2022$30.00Buy
    BofA Securities
    8/31/2022$32.00Buy
    Jefferies
    3/11/2022$25.00 → $27.00Outperform
    Raymond James
    11/29/2021$24.00Buy
    Lake Street
    More analyst ratings

    $CDRE
    SEC Filings

    View All

    SEC Form 10-Q filed by Cadre Holdings Inc.

    10-Q - Cadre Holdings, Inc. (0001860543) (Filer)

    11/4/25 4:17:42 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Cadre Holdings, Inc. (0001860543) (Filer)

    11/4/25 4:15:24 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Cadre Holdings, Inc. (0001860543) (Filer)

    11/3/25 4:16:02 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cadre Holdings downgraded by BofA Securities with a new price target

    BofA Securities downgraded Cadre Holdings from Neutral to Underperform and set a new price target of $26.00

    8/13/25 8:01:40 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings downgraded by BofA Securities with a new price target

    BofA Securities downgraded Cadre Holdings from Buy to Neutral and set a new price target of $38.00

    6/13/25 7:45:51 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    ROTH MKM reiterated coverage on Cadre Holdings with a new price target

    ROTH MKM reiterated coverage of Cadre Holdings with a rating of Buy and set a new price target of $38.00 from $32.00 previously

    2/21/24 9:51:23 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cadre Holdings Reports Third Quarter 2025 Financial Results

    Grew Quarterly Net Sales 42% and Gross Profit 66% Year-Over-Year Increased Quarterly Adjusted EBITDA of $29.8 Million and Expanded Adjusted EBITDA Margin of 19.1% Organic Backlog Increased $20 Million from Q2 to Q3 Med-Eng Awarded $50 Million IDIQ with DoD – First PO issued for $10 Million to be Shipped in 2026 Agrees to Acquire TYR Tactical, Leading Provider of Plate Carriers, Vests, Hard Armor, and Shields Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results f

    11/4/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings to Acquire TYR Tactical

    Leading Provider of Plate Carriers, Vests, Hard Armor, and Shields to Tactical Teams Expected to be Immediately Accretive and Advances Strategic Focus on Mission-Critical Products with High Margins, Strong Cash Flows Provides Significant Entry into New Markets, Particularly in European Military and Defense Management Will Host a Conference Call at 10 a.m. ET to Discuss the Transaction Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today it has entered into a definitive agreement to acquire

    10/29/25 6:00:00 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Announces Third Quarter 2025 Earnings and Conference Call Information

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the third quarter that ended on September 30, 2025, on Tuesday, November 4, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, November 5, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To

    10/22/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT Williams Brad sold $177,676 worth of shares (4,132 units at $43.00), decreasing direct ownership by 4% to 106,089 units (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    10/28/25 4:15:14 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    PRESIDENT Williams Brad sold $165,280 worth of shares (4,132 units at $40.00), decreasing direct ownership by 4% to 110,221 units (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    10/16/25 4:15:17 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    PRESIDENT Williams Brad sold $152,884 worth of shares (4,132 units at $37.00), decreasing direct ownership by 3% to 114,353 units (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    9/25/25 4:15:12 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Leadership Updates

    Live Leadership Updates

    View All

    Cadre Holdings Appoints Gianmaria Delzanno to its Board of Directors

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced the appointment of Gianmaria Delzanno to its board of directors, effective as of January 13, 2025. Current Director Nicholas Sokolow, who joined the board of Cadre's predecessor in July of 2012, will retire from the Company's board, effective as of January 31, 2025. Upon Mr. Sokolow's departure, Mr. Delzanno will replace Mr. Sokolow as the lead independent director and will also serve as Chairman of the Nominating and Corporate Governance Committee as

    1/13/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Appoints Deborah DeCotis to its Board of Directors

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced the appointment of Deborah DeCotis to its board of directors, effective immediately. With Ms. DeCotis' appointment, the Board will expand to five directors, four of whom are independent. Ms. DeCotis will also serve on the Company's Compensation Committee. Ms. DeCotis has over 45 years of financial, advisory and business operations experience with a successful track record of leadership across multiple global institutions and industries. She currently serves as Advisory Director at Morgan Stanley & Co., Inc.

    4/12/22 8:30:00 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    ElectraMeccanica Appoints Automotive Veteran, William Quigley III, to Board of Directors

    VANCOUVER, British Columbia, April 07, 2022 (GLOBE NEWSWIRE) -- ElectraMeccanica Vehicles Corp. (NASDAQ:SOLO) ("ElectraMeccanica" or the "Company"), a designer and manufacturer of electric vehicles revolutionizing the urban driving experience, today announced the appointment of William (Bill) Quigley III to its Board of Directors. Mr. Quigley is an accomplished leader with a proven track record in large enterprises specific to the automotive industry. With 30 plus years in the industry, Bill's career has included the following key roles: Executive Vice President and Chief Financial Officer at Dana Holding Corporation, an automotive, commercial vehicle and off-highway driveline, sealing an

    4/7/22 8:05:00 AM ET
    $CDRE
    $SOLO
    Industrial Specialties
    Health Care
    Auto Manufacturing
    Consumer Discretionary

    $CDRE
    Financials

    Live finance-specific insights

    View All

    Cadre Holdings Reports Third Quarter 2025 Financial Results

    Grew Quarterly Net Sales 42% and Gross Profit 66% Year-Over-Year Increased Quarterly Adjusted EBITDA of $29.8 Million and Expanded Adjusted EBITDA Margin of 19.1% Organic Backlog Increased $20 Million from Q2 to Q3 Med-Eng Awarded $50 Million IDIQ with DoD – First PO issued for $10 Million to be Shipped in 2026 Agrees to Acquire TYR Tactical, Leading Provider of Plate Carriers, Vests, Hard Armor, and Shields Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results f

    11/4/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings to Acquire TYR Tactical

    Leading Provider of Plate Carriers, Vests, Hard Armor, and Shields to Tactical Teams Expected to be Immediately Accretive and Advances Strategic Focus on Mission-Critical Products with High Margins, Strong Cash Flows Provides Significant Entry into New Markets, Particularly in European Military and Defense Management Will Host a Conference Call at 10 a.m. ET to Discuss the Transaction Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today it has entered into a definitive agreement to acquire

    10/29/25 6:00:00 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Announces Third Quarter 2025 Earnings and Conference Call Information

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the third quarter that ended on September 30, 2025, on Tuesday, November 4, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, November 5, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To

    10/22/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cadre Holdings Inc.

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    11/12/24 9:50:14 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G filed by Cadre Holdings Inc.

    SC 13G - Cadre Holdings, Inc. (0001860543) (Subject)

    2/14/24 7:58:49 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    2/12/24 4:15:31 PM ET
    $CDRE
    Industrial Specialties
    Health Care